Results 71 to 80 of about 24,077 (209)

Diabetic Gastroparesis: Epidemiology, Pathophysiology, Symptoms, and Clinical Consequences

Quality in Sport
Diabetes mellitus affects over half a billion people worldwide and is associated with numerous complications, including diabetic gastroparesis, characterized by delayed gastric emptying without mechanical obstruction.
Olgierd Dróżdż, Piotr Gacka, Marcin Dołęga, Dominika Musialska, Maciej Rabczyński, Joanna Gołda, Julia Mężyk, Aleksandra Snopkowska   +7 more
doaj   +1 more source

Multi-centric clinical study of the effect of intervention time on efficacy of gastroparesis external application prescription treatment of gastrointestinal tumor postsurgical gastroparesis

Journal of Traditional Chinese Medical Sciences, 2016
Objective: This intervention has been shown to be clinically efficacious and safe. The aim of this study was to determine the effect of different intervention times on the efficacy of gastroparesis external application prescription versus placebo for the
Qin Zhou, Minghuan Zuo, Yantao Tian, Yanbin Wang, Yingjiang Ye, Chao An, Tian Zhou, Chuanbo Liu, Kaiwen Hu, Quanwang Li   +9 more
doaj   +1 more source

Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis

Gut and Liver, 2020
Background/Aims: Ghrelin agonists are emerging prokinetic agents for treating gastroparesis. Although recent clinical trials have demonstrated their efficacy in patients with diabetic gastroparesis (DG), the impact of such agents on symptoms and gastric ...
Seung Wook Hong, Jaeyoung Chun, Jihye Kim, Jooyoung Lee, Hyun Jung Lee, Hyunsoo Chung, Soo-Jeong Cho, Jong Pil Im, Sang Gyun Kim, Joo Sung Kim   +9 more
doaj   +1 more source

Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) have been established as effective treatments for type 2 diabetes, offering benefits beyond glycaemic control; however, their associations across multiple health outcomes remain insufficiently assessed.
Dongjin Yeo, Yeona Jo, Jinyoung Jeong, Yi Deun Jeong, Ho Geol Woo, Yejun Son, Sunyoung Kim, Sang Youl Rhee, Dong Keon Yon   +8 more
wiley   +1 more source

In‐hospital mortality in gastroparesis population and its predictors: A United States‐based population study

JGH Open, 2021
Background and Aim To determine the United States‐based in‐hospital gastroparesis mortality rate and independent predictors associated with it. Methods A retrospective study was conducted using the deidentified National Inpatient Sample and Healthcare ...
Saad Saleem, Faisal Inayat, Muhammad Aziz, Eric O Then, Yousaf Zafar, Vinaya Gaduputi   +5 more
doaj   +1 more source

Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality [PDF]

, 2013
Gastroesophageal reflux disease is one of the leading gastrointestinal disorders. Current treatments include lifestyle modifications, pharmacological therapies, surgical fundoplications, and, more recently, endoscopic procedures.
Franciosa, Mark, Mashimo, Hiroshi, Triadafilopoulos, George   +2 more
core   +2 more sources

Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Objective We aim to compare second‐generation automated insulin delivery systems (AIDs) with other treatment modalities regarding both glucose management outcomes and person‐reported outcomes/experiences (PROs/PREs, measured by the Hypoglycemia Fear Survey, Hypoglycemic Confidence Scale, Hyperglycemia Avoidance Scale, Diabetes Distress Scale ...
Zekai Wu, Laure Alexandre‐Heymann, Maha Lebbar, Meryem K. Talbo, Aude Bandini, Tamanna Chahal, Caroline Grou, Virginie Messier, Valérie Boudreau, Anne‐Sophie Brazeau, Rémi Rabasa‐Lhoret   +10 more
wiley   +1 more source

Functional Dyspepsia [PDF]

, 2015
Dyspepsia is a constellation of symptoms referable to the gastroduodenal region of the upper gastrointestinal tract. Functional dyspepsia, a relapsing and remitting disorder, is the most common cause of these symptoms.
Alexander C. Ford, Dan L. Longo, Friesen CA, Lan L, Moayyedi P, Moayyedi P, Nicholas J. Talley, Soo S, Vanheel H   +8 more
core   +1 more source

Age‐related variations in clinical characteristics of patients with diabetic foot ulcers

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Objective Diabetic foot ulcers (DFUs) have increasingly affected younger populations. This study aimed to analyze the clinical characteristics of DFUs in different age groups of diabetic patients with foot ulcers. Methods This is a retrospective cohort study of diabetic patients with foot ulcers admitted to West China Hospital, Sichuan ...
Hong‐ping Gong, Yan Ren, Thet Htar Swe, Zhen‐yi Li, Pan‐pan Zha, Da‐wei Chen, Xing‐wu Ran, Chun Wang   +7 more
wiley   +1 more source

Diabetic gastroenteropathy: Associations between gastrointestinal symptoms, motility, and extraintestinal autonomic measures

Neurogastroenterology &Motility, EarlyView.
We found no associations between gastrointestinal and extraintestinal measures of diabetic autonomic neuropathy. Nonetheless, gastrointestinal symptoms increased with the severity of cardiovascular autonomic neuropathy and were associated with gastrointestinal measures.
Ditte S. Kornum, Christina Brock, Tina Okdahl, Davide Bertoli, Huda Kufaishi, Anne‐Marie Wegeberg, Katrine L. Høyer, Esben B. Mark, Birgitte Brock, Christian S. Hansen, Filip K. Knop, Asbjørn M. Drewes, Klaus Krogh   +12 more
wiley   +1 more source